These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15628771)

  • 21. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
    Ikeguchi M; Makino M; Kaibara N
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results.
    Honda J; Sasa M; Moriya T; Bando Y; Hirose T; Takahashi M; Nagao T; Tangoku A
    J Med Invest; 2008 Feb; 55(1-2):54-60. PubMed ID: 18319546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression levels in tumor and normal tissue specimens of T3 human colorectal carcinoma.
    Okita A; Tsukuda K; Murakami M; Ota T; Doihara H; Suda M; Nakano T; Matsuoka K; Suzuki E; Naito M; Andou A; Shimizu N
    Surg Today; 2006; 36(4):348-53. PubMed ID: 16554992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
    Ogata Y; Matono K; Sasatomi T; Ishibashi N; Torigoe S; Fukumitsu T; Mizobe T; Yamashita N; Yanagawa T; Shirouzu K
    J Surg Oncol; 2006 Jan; 93(1):47-55. PubMed ID: 16353181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer.
    Wang C; Weng Y; Wang H; Shi Y; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):494-9. PubMed ID: 20714877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Takahashi K; Saito T
    Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential].
    Stepanova EV; Bokhian BIu; Petrovichev NN; Lichinitzer MR
    Vopr Onkol; 2005; 51(3):314-6. PubMed ID: 16279094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer.
    Miyake K; Imura S; Yoshizumi T; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2007 Apr; 12(2):111-9. PubMed ID: 17443278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
    Takechi T; Okabe H; Ikeda K; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
    Oncol Rep; 2005 Jul; 14(1):33-9. PubMed ID: 15944764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio in pancreatic cancer].
    Yu XJ; Jiang YJ; Fu DL; Ni QX
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):618-20. PubMed ID: 15634525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
    Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
    Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
    Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues.
    Loo WT; Chow LW; Suzuki T; Ono K; Ishida T; Hirakawa H; Ohuchi N; Sasano H
    Anticancer Res; 2009 Jul; 29(7):2525-30. PubMed ID: 19596923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.
    Ouchi KF; Yanagisawa M; Sekiguchi F; Tanaka Y
    Cancer Chemother Pharmacol; 2006 May; 57(5):693-702. PubMed ID: 16362295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.
    Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K
    Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.